DK Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	118,021	117,062	-	-	-	-
Enterprise Value	149,751	147,385	-	-	-	-
Last Close Price	3690.00	3660.00	-	-	-	-
PE Ratio	13.42	13.52	-	-	-	-
PS Ratio	0.91	0.90	-	-	-	-
PB Ratio	0.90	0.89	-	-	-	-
P/TBV Ratio	0.94	0.93	-	-	-	-
P/OCF Ratio	272.16	269.95	-	-	-	-
EV/Sales Ratio	1.15	1.13	-	-	-	-
EV/EBITDA Ratio	7.70	7.58	-	-	-	-
EV/EBIT Ratio	11.48	11.30	-	-	-	-
Debt / Equity Ratio	0.30	0.30	0.43	0.49	0.46	0.28
Debt / EBITDA Ratio	2.00	2.00	2.56	4.03	4.81	2.55
Debt / FCF Ratio	-	-	7.01	-	-	-
Net Debt / Equity Ratio	0.24	0.24	0.39	0.45	0.41	0.18
Net Debt / EBITDA Ratio	1.63	1.63	2.30	3.71	4.29	1.65
Net Debt / FCF Ratio	-6.04	-6.04	6.30	-4.66	-1.84	-0.61
Asset Turnover	0.64	0.64	0.71	0.70	0.69	0.76
Inventory Turnover	2.51	2.51	2.52	2.75	3.45	4.90
Quick Ratio	1.23	1.23	1.11	0.98	1.09	1.03
Current Ratio	1.72	1.72	1.84	1.62	1.72	1.46
Return on Equity (ROE)	7.32%	7.32%	2.22%	4.46%	4.90%	7.45%
Return on Assets (ROA)	3.98%	3.98%	4.02%	3.10%	2.49%	3.16%
Return on Invested Capital (ROIC)	6.44%	6.75%	3.93%	5.49%	4.44%	7.94%
Return on Capital Employed (ROCE)	9.50%	9.50%	9.30%	7.40%	5.40%	7.30%
Earnings Yield	7.34%	7.40%	-	-	-	-
FCF Yield	-4.45%	-4.49%	-	-	-	-
Buyback Yield / Dilution	-12.21%	-12.21%	-2406.42%	-0.00%	-0.01%	2.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.